Genoil (GNOLF) Research & Development (2009 - 2013)

Genoil (GNOLF) has 5 years of Research & Development data on file, last reported at $33461.0 in Q2 2013.

• On a quarterly basis, Research & Development rose 48.49% year-over-year to $33461.0 in Q2 2013; TTM through Jun 2013 was $77921.1, a 59.23% decrease from a year earlier, with the FY2013 full-year figure at $41644.5, down 16.93% from the prior year.
• Research & Development for Q2 2013 stood at $33461.0, up from $8624.3 in the prior quarter.
• Over the last five years, Research & Development for GNOLF reached as high as $377.8 billion in Q4 2010 and fell as low as $4609.7 in Q4 2009.
• Historically, Research & Development has averaged $21.0 billion across 5 years, with a median of $10539.7 in 2010.
• Across the five-year window, Research & Development soared 8195151858.47% in 2010 and plunged 100.0% in 2011, its largest moves.
• Year by year, Research & Development stood at $4609.7 in 2009, then surged by 8195151858.47% to $377.8 billion in 2010, then plunged by 100.0% to $45043.1 in 2011, then slumped by 73.44% to $11964.0 in 2012, then surged by 179.68% to $33461.0 in 2013.
• Per Business Quant data, the three most recent Research & Development figures were $33461.0 in Q2 2013, $8624.3 in Q1 2013, and $11964.0 in Q4 2012.